We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Scoring Angioplasty Platform Treats Peripheral Artery Disease

By HospiMedica International staff writers
Posted on 25 May 2021
An innovative metal-alloy scoring sheath facilitates dilation of stenotic atherosclerotic material in the peripheral vasculature.

The Transit Scientific (Park City, UT, USA) XO Score platform is designed to aid low-pressure lesion dilatations in patients with peripheral artery disease (PAD), including in the popliteal, infrapopliteal, and renal vasculature, as well as in both native and synthetic arteriovenous (AV) dialysis fistulae. More...
The low-profile, flexible, metal-alloy exoskeleton has 22 scoring struts (0.25mm, 0.35mm, or 0.50mm deep) that enable precise dilation across a range of lesion types, using standard off-the-shelf percutaneous transluminal angioplasty (PTA) balloons.

The struts, which lay flat during insertion, rotate 90° into function during balloon inflation in order to score the vessel walls, and then rotate 90° back during deflation. The XO Score is available in 6.3Fr diameter and 65cm or 125cm working lengths, and can be used with a number of 4-8mm diameter and 20-40mm long PTA balloons. Future ultra-low-profile over-the-wire and rapid-exchange versions are under development for smaller vessels and for coronary use.

“The rotating struts allow clinicians to vary scoring depth without increasing device profile. We've been thrilled to see the effective low-pressure dilatation and luminal gain achieved using our XO Score platform to treat a broad range of lesion types,” said Greg Method, President of Transit Scientific. “XO Score offers a direct value proposition; One XO Score and an off-the-shelf PTA balloon will cost less than one specialty PTA scoring or cutting technology.”

“We need novel, safe, and appropriately aggressive vessel prep devices to continue fighting the increasingly difficult stenotic lesions encountered in critical limb ischemia patients,” commented Jihad Mustapha, MD, of Advanced Cardiac & Vascular Center (Grand Rapids, MI, USA). “The ability to scale this technology down to below 3Fr is especially important for treatment of pedal loop stenosis and deployment in the tibiopedal junction.”

PAD is caused by atherosclerosis, and results in severe pain in the feet or toes, even while resting, due to poor circulation. Complications include sores and wounds that will not heal in the legs and feet that if left untreated, could result in amputation of the affected limb. CLI is a severe blockage in the arteries of the lower extremities, which markedly reduces blood-flow; it is a serious form of PAD, but less common than claudication.

Related Links:
Transit Scientific


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.